biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Well We Will Soon Know Won’t We

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Aug 08, 2022 9:37pm

174 Views

Post# 34880490

RE:RE:RE:RE:RE:RE:RE:Well We Will Soon Know Won’t We

On further thought why are you replying to a three day old post ....

...when BTI is up 38.46% today!

You should shouting from the rooftops!

And just think about those cheap shares you bragged about buying not very long ago.

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia